acamprosate has been researched along with Alcoholic Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Falker, C; Garcia-Tsao, G; Kaplan, DE; Mahmud, N; Rabiee, A; Taddei, T | 1 |
| Avanceña, ALV; Hutton, DW; Mellinger, JL; Miller, N; Uttal, SE | 1 |
| Capron, D; Capron, JP; Delgrange, T; Duron, B; Khater, J | 1 |
1 trial(s) available for acamprosate and Alcoholic Cirrhosis
| Article | Year |
|---|---|
[Effect of acute administration of acamprosate on the risk of encephalopathy and on arterial pressure in patients with alcoholic cirrhosis].
Topics: Acamprosate; Administration, Oral; Adult; Blood Pressure; Double-Blind Method; Drug Evaluation; Evoked Potentials, Visual; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Placebos; Reference Values; Risk Factors; Taurine | 1992 |
2 other study(ies) available for acamprosate and Alcoholic Cirrhosis
| Article | Year |
|---|---|
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Naltrexone; Retrospective Studies | 2023 |
Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis.
Topics: Acamprosate; Aged; Alcohol Deterrents; Alcoholism; Cohort Studies; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Naltrexone; Quality-Adjusted Life Years; Treatment Outcome | 2021 |